Christian Rolfo
@ChristianRolfo
Followers
6,280
Following
1,734
Media
1,151
Statuses
8,053
Assoc Director Clinical Research. Center for Thoracic Oncology.Tisch Cancer Institute. Prof. Icahn School of Medicine at Mount Sinai. Liquid Biopsy. T/RT my own
New York, NY, US
Joined September 2017
Don't wanna be here?
Send us removal request.
Explore trending content on Musk Viewer
Mother's Day
• 1167929 Tweets
Arsenal
• 355563 Tweets
Feliz Dia
• 309445 Tweets
Mães
• 264314 Tweets
Moms
• 259220 Tweets
#鬼滅の刃
• 173388 Tweets
Manchester United
• 110617 Tweets
NAYEON
• 90107 Tweets
#MUNARS
• 69554 Tweets
Saka
• 47175 Tweets
Casemiro
• 45796 Tweets
Karagümrük
• 41651 Tweets
Old Trafford
• 37759 Tweets
Man U
• 32490 Tweets
ヒロアカ
• 32366 Tweets
Amad
• 30586 Tweets
Garnacho
• 28526 Tweets
Evans
• 26647 Tweets
Arapça
• 25556 Tweets
Antony
• 23445 Tweets
Arteta
• 22643 Tweets
Trossard
• 22530 Tweets
Hojlund
• 18909 Tweets
ارسنال
• 15321 Tweets
Onana
• 14686 Tweets
Amrabat
• 14104 Tweets
Partey
• 13846 Tweets
アニオリ
• 11762 Tweets
伊黒さん
• 11084 Tweets
📣Proud to announce our Practical Medical Oncology Textbook 📘 📕 a great collaboration 🇺🇸🇮🇹🇧🇪Didactically structured with a wealth of figures, schemes, clinical cases and expert tips
@antoniorusso_pa
@unipait
@IcahnMountSinai
@UAntwerpen
@myESMO
@ASCO
8
29
196
We started
#WCLC22
with the
@IASLC
Academy workshop! A great initiative to support career development. Congrats to the awardees and thanks to the faculty!
@JPatelMD
@marinagarassino
@JackWestMD
@danieltanmd
@StephenVLiu
@karenkellymd
@HwakeleeMD
@RManochakian
@Piuchagarrido
10
18
131
📣Our paper on NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types it’s online
@alexdrilon
@Al3ssandroRusso
@DavidHongMD
@drgandara
@JessicaJLinMD
@CarolineMccoach
@ntrkconnectinfo
@NTRKers
1
43
126
Small cell lung cancer: Novel treatments beyond immunotherapy, a great collaboration with
@elisagiovan
@MarcelloTiseo
and team for this overview in new biomarkers at SCLC !
@OncoAlert
@isliquidbiopsy
@lcsmchat
@ELS_Oncology
0
44
115
of the
#10yearchallenge
I choose these two photos that shown the radical change in the landscape of lung cancer treatment in the last 10 years. amazing!!
#LCSM
let's go for more!
2
55
107
I’m leaving
@UMmedschool
after 3 years of a great experience! Thanks to patients, team and staff for their kindness and support. A privilege to work in this great institution, the first public school of medicine in 🇺🇸. I’ll bring you all in my heart!
@RaneeMehra
@KatherineScilla
14
4
111
Very honored to serve as Chair of the Educational Committee at
@IASLC
2021-2023 and continue to collaborate with the upcoming chair
@PranshuMohindra
& an extraordinary group of members from around the world. Thanks
@IASLC
for the support!
@karenkellymd
@HwakeleeMD
#WCLC23
4
12
110
Great collaboration with
@AndresFCardonaZ
and team in this paper giving insights on Bispecific Antibodies in Cancer Immunotherapy: A Novel Response an Old Question
#mdpipharmaceutics
@Al3ssandroRusso
@lucia_zatarain
@ogarrieta
@ddemiguelperez
@OncoAlert
3
28
95
NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types
@drgandara
@alexdrilon
@Al3ssandroRusso
@isliquidbiopsy
@MSHSThoracicOnc
@oncoalert
@BrJCancer
0
29
91
Our new paper How I treat ALK-positive non-small cell lung cancer | published today in ESMO Open
@ESMO_Open
@UMGCCC
@UMmedschool
@alk_fusion
#LCSM
#oncoalert
3
42
89
“Liquid AND tissue biopsy” great overview by
@UmbertoMalapel1
on the complementary approach of both sources for biomarkers in NSCLC at
#WCLC23
@IASLC
@isliquidbiopsy
3
20
88
Our publication summarizes the genomic landscape in Small Cell Lung Cancer. New opportunities to personalize treatment. Great team
@VDenninghoff
@Al3ssandroRusso
@UmbertoMalapel1
@ddemiguelperez
@AndresFCardonaZ
@lcsmchat
@IASLC
@isliquidbiopsy
4
30
86
An honor to serve in ISLB
@isliquidbiopsy
We will continue to work for made Liquid Biopsy a tool available worldwide, increasing the opportunities for research to helping patients and promoting education. We have a great team! Join us!
🗣️The ISLB welcomes Dr Christian Rolfo as its new appointed President.
Dr Rolfo is a well accomplished Oncologist with extensive experience in
#liquidbiopsy
and will be of great value to the Society.
👏Congratulations Dr Rolfo!!!
11
11
55
15
11
86
Biomarker in liquid biopsy for lung cancer appears more accurate predicting immunotherapy response than tumor biopsy: Study findings could be developed into less-invasive method
@ddemiguelperez
@Al3ssandroRusso
@ogarrieta
@AndresFCardonaZ
@isliquidbiopsy
0
29
81
Despite the great data on targeted therapy 🎯 testing it’s still a big barrier! Only 50% of NSCLC patients are testing for ALK ROS1 BRAF EGFR (and PDL1)It’s not acceptable. Certainly higher in other world regions Equal test access its mandatory!
@isliquidbiopsy
#ASCO21
@lcsmchat
2
34
81
We had a great session at
#ELCC22
on MRD son lung cancer 🫁🩸with an excellent panel of experts
@ShirishGadgeel
Francesco Grossi and Paul Hofman. An amazing discussion. Thanks
@myESMO
and
@IASLC
for the terrific program.
@isliquidbiopsy
@OncoAlert
@MSHSThoracicOnc
@TischCancer
0
25
78
Congrats 🎉 to my dear friend
@UmbertoMalapel1
for be promoted to Associate Professor at Univerità Federico II Naples 🇮🇹
@UninaIT
. Well deserved!
@isliquidbiopsy
24
7
79
This year ISLB
@isliquidbiopsy
it’s honored to confer The ISLB Research Award 🥇 to Prof.
@CharlesSwanton
a visionary in liquid biopsy with outstanding contributions in the field. Join us on October 22th for his lecture “Tumor evolution through LB”
2
12
80
Check our last paper about RET fusions in solid tumors. With new drugs as Selpercatinib (LOXO292) and BLUE667 new promising opportunities for this sub-population across several tumors.
@UMGCCC
@OncoAlert
@myESMO
1
26
75
Very proud of the collaboration with
@antoniorusso_pa
,Marc Peeters and Lorena Incorvaia in this textbook didactically structured with cases to foster the learning. This is an invaluable, practice-oriented tool for students, oncology residents and young professionals
@OncoAlert
0
12
73
Very happy to see our chapter in fusions on the ESMO Handbook of Targeted Therapies and Precision Oncology with stalker editors
@Sandra_Misale
@HaanenJohn
@ILugowska
and
@caliraf
@myESMO
thanks to the coauthors
@Al3ssandroRusso
@UmbertoMalapel1
@fred_hirsch
& Phil Mack
2
12
73
Great day with the
@IASLC
Academy participants!
#WCLC23
@marinagarassino
@RManochakian
@UmbertoMalapel1
@Piuchagarrido
@triparnasen
@karenkellymd
@HwakeleeMD
@LuisRaezMD
@danieltanmd
1
17
74
Very proud of ISLB
@isliquidbiopsy
team launching the first issue of our “The Journal of Liquid Biopsy”, together with
@CHematology
our official journals. Thanks to authors, our board &
@UmbertoMalapel1
our editor in chief for leading this journal! 👏👏
10
23
72
Honored to present with a great international team at
#AACR2021
the safety data of the INTR
@PID
LUNG024 trial with dual PDL1-TGFB inhibitor Bintrafusp Alfa in combination with chemotherapy Im stage IV NSCLC.
@AACR
@CD_AACR
@OncoAlert
@IASLC
@lcsmchat
@UMGCCC
@UMmedschool
0
17
72
Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Cohort of EGFR-Mutant and RET Fusion + Lung Cancers
@alexdrilon
@JuliaRotow
@RETpositive
@RetRenegades
@EGFRResisters
1
34
71
Liquid biopsy in lung cancer I’ll discuss the evidence in NSCLC with the great participation of
@DrSanjayPopat
and
@UmbertoMalapel1
at the
@ESOncology
e-learning session on 2/27. See the link!
@isliquidbiopsy
@IASLC
1
23
66
📣A must to read paper 📰👩💻👨💻🧑💻🧬 🩸 DNA methylation: a historical perspective: Trends in Genetics.
@isliquidbiopsy
@OncoAlert
@AL_Mattei
1
21
68
Very nice session on ADC in NSCLC at
#WCLC23
@IASLC
with excellent speakers and good friends
@UmbertoMalapel1
@dplanchard
& Ross Camidge.
5
14
69
At
@IASLC
#LALCA2021
we have the privilege of a Keynote Presentation by
@AndresFCardonaZ
on Genetic Ancestry Contributes to Somatic Mutations in Lung Cancer from Mixed Latin American Populations. Don’t miss it!🆓👩💻👨💻🧑💻
@LuisERaez1
@LealTiciana
@edgardo_ny
1
14
60
Healthy cells in smokers’ lungs have a high burden of mutations, similar to the mutational profile of lung cancer.
#LCSM
@OncoAlert
0
32
65
Vamos Argentina!!! Campeón Mundial!!! 🇦🇷🇦🇷🇦🇷👏👏👏⚽️⚽️🏆🏆🏆
4
1
67
Today is the
#WorldLungCancerDay
a day to celebrate patients, raise awareness, continue with advances in research, remember to
#nostigma
and the necessity of more funds for research worldwide
1
23
64
FDA has granted Breakthrough Therapy Designation for JNJ-61186372 (JNJ-6372) for the treatment of patients with metastatic NSCLC with epidermal growth factor receptor (EGFR) Exon 20 insertion mutations
@OncoAlert
#lcsm
@EGFRResisters
1
21
65
Finally I got mine
#DumaLab
mug! Thanks
@NarjustDumaMD
! things like this turn a cloudy day into a sunny one!🌞🌞🌞
4
2
65
Our paper: Liquid Biopsy in Lung Cancer Screening: Contribution Metabolomics. Results of A Pilot Study A panel consisting of 14 metabolites, was identified that correctly discriminated lung cancer patients from controls
@isliquidbiopsy
#lcsm
@OncoAlert
2
29
60
Important info just published in Science.
#COVID
ー19 The pharmacokinetic characterization of the optimized inhibitor reveals a pronounced lung tropism and suitability for administration by the inhalative route.
1
38
58
MET amplification in EGFR resistance tackled by MoAb and TKI, the importance of identity the mechanism of resistance . Great talk by
@JordiRemon
at
#WCLC22
@IASLC
@UmbertoMalapel1
@MartinReck2
@OncoAlert
0
15
64
📣Our paper “Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma” is online now!
@ElsevierConnect
@ddemiguelperez
@Al3ssandroRusso
@TischCancer
@IcahnMountSinai
@MSHSThoracicOnc
@curemeso
5
22
64
Our paper Efficacy and Safety of Pembrolizumab Plus Docetaxel vs Docetaxel in NSCLC PROLUNG Phase 2 Trial (including EGFR+) A great job lead by
@ogarrieta
@JAMAOnc
@AndresFCardonaZ
#lcsm
@EGFRResisters
@OncoAlert
2
29
58
The next frontier of early lung cancer and minimal residual disease detection: is multiomics the solution?
@Al3ssandroRusso
@UmbertoMalapel1
@eBioMedicine
@isliquidbiopsy
@TischCancer
1
22
62
Happy to be part of a great team at
@UMGCCC
who is working hard to continue with our care for cancer patients! All together we will overcome this!
@OncoAlert
#COVID19
2
5
59
Opening the TKI session
@StephenVLiu
with a terrific overview on the current landscape in targeted therapies at
#RomeLung23
it’s always a pleasure to her Stephen’s presentations
@FedericoCappuz1
@OncoAlert
@IASLC
@isliquidbiopsy
1
9
63
Starting the
#WCLC23
🇸🇬with our IASLC Academy! Very excited to meet all the future leaders in thoracic oncology!
@IASLC
@RManochakian
@marinagarassino
@AnneTsao2
@LuisRaezMD
@Piuchagarrido
@JPatelMD
@JackWestMD
@karenkellymd
@HwakeleeMD
3
13
61
🚨Just in time for
#TTLC23
the
@IASLC
molecular testing for Targeted Therapy is online! Happy to collaborate in the
#liquidbiopsy
chapter with Maria Arcila and Fernando Lopez Rios.
0
22
60
Thanks my friend. Happy to join
@MSHSThoracicOnc
and the great group lead by dr Hirsch
@fred_hirsch
at
@TischCancer
as associate director of clinical research and professor at
@IcahnMountSinai
looking forward to be part of this important institution and work for NYC community
@ChristianRolfo
to Head Thoracic Research at Mount Sinai . We are proud of you mu Big Friend!
@OncoAlert
@isliquidbiopsy
@JTOonline
@IASLC
@CHematology
@Al3ssandroRusso
@PasqualePisapia
@fred_hirsch
@drgandara
@giorgioscaglio3
@curijoey
@lcsmchat
@APassaroMD
14
8
54
12
3
60
Lung cancer on never smokers exposed to wood-smoke and it molecular profile by
@ogarrieta
opened the door for a research line on this field. Presented by
@AndresFCardonaZ
at the
#LALCA21
@iaslc
keynote.
0
10
57
Happy to share our great collaboration with
@ANaingMD
and
@rrcolen
among a great group with
@VivekSubbiah
@HajjarJoud
Our radiomics-based signature predicting pembrolizumab response in patients with advanced rare cancer
@OncoAlert
@sitcancer
@AACR
@ASCO
1
16
59
Nice to see this campaign for screening of Lung Cancer 🫁🩻 in the bus stop🚏🚍 this morning.
#LungCancerAwarenessMonth
Congrats
@LungAssociation
for the initiative!
Important: we need tools for screening in never smokers hoping in liquid biopsy contribution
@isliquidbiopsy
1
12
58
Very well deserved award to Rafael Rosell, a friend a mentor and an extraordinary researcher. Congrats and thanks for all your mentoring.
@IASLC
#WCLC22
@oncorosell
@gecp_org
4
11
57
Very happy to see our
#COVID19
and lung cancer paper in the
@JTOonline
cover! A team effort lead by
@fred_hirsch
with
@florian_krammer
@acmoorephd
@Al3ssandroRusso
Adolfo Garcia Sastre & more!
@MSHSThoracicOnc
@IcahnMountSinai
@TischCancer
@OncoAlert
2
11
56
Happy to announce the IASLC Liquid Biopsy Meeting in Baltimore 7-9 May 2020 to discuss all these advances and more!
@drgandara
@IASLC
@CharuAggarwalMD
@geoff_oxnard
Natasha Leigh, and a full faculty of experts.
T-7 to 2020!
#DecadeInReview
#7
of
#Top10
advances in
#LungCancer
is Plasma based testing, including
#NGS
for actionable mutations. Making
#PrecisionMedicine
practical, and real for our pts
@geoff_oxnard
@JSabari
@drgandara
@ChristianRolfo
@JackWestMD
@benlevylungdoc
@OncoAlert
0
8
27
2
13
57
Today is the
#WorldLungCancerDay
. A day dedicated to celebrate our patients, caregivers, advocacy groups and colleagues and to remind the need to continue the research and the support and awareness in this disease. My word today is HOPE
@IASLC
#LCSM
@LUNGevity
@TheALCF
@AEACaP
1
36
56
Congrats
@DrAlexAdjei
for the ESMO lifetime Achievement Award 🥇
@myESMO
, very well deserved!! 🎉🎉
@JTOonline
@IASLC
@MayoClinic
1
6
58
Congrats
@bensolomon1
for the great discussion of the unprecedented OS data of ADAURA. Important to guarantee access to medication for our patients around the world and TESTING! Great slide by
@jillfeldman4
on toxicity considerations.
#ASCO23
@EGFRResisters
@asco
@isliquidbiopsy
3
15
58
Thanks to Lung Cancer Research Foundation
@lcrf_org
for the lung cancer treatment research focus grant m. It’s a great opportunity for our community in Maryland
@UMGCCC
@UMmedschool
thanks to our team for excellent teamwork!
6
10
58
Very happy to see our journal
@CHematology
is continue to growing. The IF is now 6.312! This would not be possible without the great work from all the stellar editorial board
@ELS_Oncology
and the terrific deputy editors
@elisagiovan
&
@UmbertoMalapel1
@ESOncology
@isliquidbiopsy
3
18
56
Terrific work of
@CharuAggarwalMD
and colleagues on how to improve the time to get testing results. This requires a multidisciplinary team effort! Impressive time shortening impacting positively in patients care. A great model!
@gotoPER
@benlevylungdoc
@DrSteveMartin
@OncoAlert
2
5
53
Brilliant presentation by my friend
@AndresFCardonaZ
at
#LALCA2023
@IASLC
on research in Lung Cancer 🫁🧪🔬he is a role model of investigator for new generations of researchers in LATAM.
3
8
54
Nice collaboration with
@LuisERaez1
and
@Al3ssandroRusso
& Daniel Rosas for the NRG1 druggable target 🎯 in Lung Cáncer. Open access
@isliquidbiopsy
@OncoAlert
@IASLC
@myESMO
@AACR
@ASCO
1
28
54
Absolutely excellent discussion by
@BenjaminBesseMD
on the Phase III trials for RET fusion positive (selpercatinib) and EGFR exon 20 (Mobicertinib) vs Chemotherapy. Do we really need those trials? Important point for discussion I’m TKI.
@myESMO
#ESMO23
@OncoAlert
3
13
54
Great opening of the
#simposioCTIC
in 🇨🇴 Colombia. CTIC así an impressive new Cancer Center in Bogota who will help thousands of patients in the region. Congrats for this great effort!
@AndresFCardonaZ
@GlopesMd
@ogarrieta
@GWerutsky
@OncoAlert
0
3
51
Great session on
#liquidbiopsy
and tissue technologies in
#NSCLC
with a stellar panel Caroline Dive ,Lilian Siu, Junko Tanizaki and
@UmbertoMalapel1
during
#WCLC22
thanks to
@IASLC
to include such important topic in the agenda and to the numerous audience!
1
5
54
🚨 our comment on
@JCOPO_ASCO
on Skipping or Not Skipping? That's the Question! An Algorithm to Classify Novel MET Exon 14 Variants 🧬 in NSCLC 🫁 🩸
@Al3ssandroRusso
@UmbertoMalapel1
@TischCancer
@metcrusaders
@IASLC
@isliquidbiopsy
@ASCO
1
18
51
Thanks to the ACM Academia Ciencias Médicas in Cordoba 🇦🇷 and specially to the Academic Prof
@NormaPilnik
for this important honor from my peers in my born city
@isliquidbiopsy
@unc_cordoba
@MedicasUNC
Congratulations to
@ChristianRolfo
, elected as a member of the Academy of Medical Sciences in Cordoba.
#liquidbiopsy
#cancer
@IcahnMountSinai
3
2
26
10
4
53
#ESMO23
was a great congress and a excellent opportunity for ISLB to meet our members and new ones!
#liquidbiopsy
is a very dynamic field and certainly our society is contributing in education and policy. Join us in Madrid in November 19-21 for
#ISLB23
@isliquidbiopsy
@myESMO
0
15
53
Very honored to participate in this
@ASCO
Plenary Series discussing about
#liquidbiopsy
biomarkers in clinical trials design with great colleagues
@SalemGIOncDoc
@breelynwilkyMD
@seppobauer
Don’t miss it!
@isliquidbiopsy
@DrChoueiri
@MLJohnsonMD2
‼️ The January
#ASCOPlenarySeries
session will highlight the role of
#ctDNA
in predicting treatment efficacy in GIST & other tumors.
📅 Live presentation 1/24 @ 3 PM ET. Details ➡️
@OncoAlert
@SalemGIOncDoc
@seppobauer
@breelynwilkyMD
@ChristianRolfo
0
10
19
1
13
52
Impressive agenda and faculty in the International Summit on Lung Cancer for experts. Organized by Federico Cappuzzo, Sílvia Novello and Giorgio Scagliotti
@giorgioscaglio3
in the beautiful Rome 🇮🇹🇪🇺 a great forum to discuss about last advances
@OncoAlert
@isliquidbiopsy
@iaslc
1
10
51
Happy to share the spot we did for lung cancer awareness with Ricky Rubio Foundation and great friends
@DrViteri
@delvysra
@marinagarassino
@rickyrubio9
@UMGCCC
@UMmedschool
#LCSM
@OncoAlert
@myESMO
@ASCO
@NBA
@Suns
@AACR
0
19
51
Great session with
@TonyMok9
and
@max_diehn
to discuss
#liquidbiopsy
in Lung Cancer
@myESMO
don’t miss it! Happy to share the experiences with two great friends and outstanding experts in the field!
@OncoAlert
@isliquidbiopsy
Learn about the role of plasma-based
#cfDNA
testing in managemt of EGFR or ALK positive
#lungcancer
. Submit yr questions & participate in this live discussion
27 Oct 16:00 CEST; 10:00 EDT; 22:00 SGT
👉Register now (free):
#lcsm
@TonyMok9
@ChristianRolfo
1
16
27
0
17
50
Great talk as always by
@UmbertoMalapel1
at
#WCLC22
on biomarkers In NSCLC
@MartinReck2
@JordiRemon
@IASLC
1
10
51
📣📣thanks to the more than 1500 participants in our ISLB Annual Meeting
#ISLB2021
!! A stellar faculty for a very comprehensive agenda. The presentations will remain on demand for 4 months in our website. Thanks to sponsors and all the ISLB family!
@isliquidbiopsy
@OncoAlert
0
14
50
Very interesting data on Intracranial efficacy of selpercatinib in RET fusion-positive NSCLC on the LIBRETTO-001 trial our publication on
@CCR_AACR
@VivekSubbiah
@alexdrilon
@NTRKers
@ntrkconnectinfo
@OncoAlert
@MSHSThoracicOnc
@UMmedschool
@lcsmchat
1
20
50
Congrats
@LuisPaz_Ares
and all the autore for the publication on
@NEJM
the same day the date were presented in
#ESMO23
#ESMO23
Dr.
@LuisPaz_Ares
presents the phase II DeLLphi-301 study of tarlatamab in
#SCLC
. Randomized to tarlatamab 10mg weekly versus a dose escalation arm starting at 1mg then 100mg. Part 2 expanded 10mg. Part 3 looked at a reduced inpatient monitoring strategy.
1
13
57
1
8
51
How I Treat ALK-Positive NSCLC | Oncology Learning Network Thqnks for the opportunity to discuss about this hot topic!
@alk_fusion
@OncoAlert
#LCSM
3
27
49
Check our new paper Liquid biopsy tracking of lung tumor evolutions over time: Expert Review of Molecular Diagnostics
@isliquidbiopsy
@UmbertoMalapel1
@RaneeMehra
@KatherineScilla
@UMGCCC
@UMmedschool
5
15
49
Hoy es el Día Mundial del
#C
áncer de
#Pulm
ón. Visibilidad, apoyo, investigación, confianza. Desterremos el estigma social. Yo me uno a la campaña del
@gecp_org
Sube una imagen tapándote parte del rostro con los hashtags
#NoignoroCP
#NoculpoCP
¿Te apuntas? RT y foto!
#LCAM
#LCSM
1
18
50
Very interesting presentations and discussions at our IASLC Academy!
#WCLC23
@IASLC
@MarianaBrandao0
@MMarmarelis
@DiFedericoMD
@mkbaine
@drshrinidhi2020
@pecci_federica1
@pedrofsrocha
@RManochakian
@AnneTsao2
@marinagarassino
@LuisRaezMD
0
14
50
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC | Cancer Discovery | American Association for Cancer Research
@FSkoulidis
@KRASKickers
@isliquidbiopsy
@CD_AACR
0
13
48
Great lecture by
@UmbertoMalapel1
on
#liquidbiopsy
for therapy selection in NSCLC at the International Summit on Lung Cancer in Rome 🇮🇹
@isliquidbiopsy
@giorgioscaglio3
@OncoAlert
3
7
46
Super proud of
@ddemiguelperez
receiving the
@IASLC
Educational Award🥇 at
#LALCA23
giving an oral presentation on our work in EVs TGF-B as a biomarker for ICPi in NSCLC. Great team effort! Thanks Diego for your commitment and motivation!
@TischCancer
@MSHSThoracicOnc
👏👏👏
5
6
47
Associations between the gut microbiome and fatigue in cancer patients. Congrats
@HajjarJoud
@ANaingMD
@FilipJankuMD
@DavidHongMD
and team!
@OncoAlert
0
25
45
Our ISLB team is getting all ready to start
#ISLB23
tomorrow !
Super happy to receive you all in Madrid!
Thanks to our great staff!!
@isliquidbiopsy
@ICS_Events
Welcome also to the participants on demand!
Our program:
6
13
48
Here our
#ISLB2021
best abstracts! 🥇🥈🥉visit them at
@isliquidbiopsy
congress website .
@UmbertoMalapel1
@drgandara
@MJOSESERRANO19
@ElJanLe
@jjdmochon
@MCristofanill
@OncoAlert
@VJOncology
2
18
47
Our paper is cover of this month issue! lung cancer interception by liquid biopsy & metabolomics
@MDPIOpenAccess
@isliquidbiopsy
#oncoalert
#lcsm
@IASLC
1
17
47
The most incredible group!! Thanks for your commitment with ISLB ! We are proud to launch a completely free worldwide event in
#liquidbiopsy
thanks to their great job!
@isliquidbiopsy
@MJOSESERRANO19
@UmbertoMalapel1
@ElJanLe
@drgandara
@MCristofanill
@jjdmochon
@LacortMedical
👏
1
17
48
Our first day at the
@IASLC
Academy is ongoing!! Very excited to this worldwide panel of participants and great faculty!
@HwakeleeMD
@marinagarassino
@Piuchagarrido
@TonyMok9
@JackWestMD
@acmoorephd
@danieltanmd
and more!
3
10
47
Thanks
@myESMO
for the interview on
#liquidbiopsy
in multi-cancer early detection data presented tomorrow at
#ESMO21
and the use of the levels of evidence (
@OncoKB
) in agnostic tumors
@isliquidbiopsy
@OncoAlert
@MSHSThoracicOnc
@TischCancer
@IcahnMountSinai
#ESMO21
: Multi-omics approaches incorporating cell-free DNA & circulating
#tumour
DNA show potential in early
#cancer
detection and could help personalise treatment by tumour characteristics. Interview with 👉
@ChristianRolfo
#liquidbiopsy
#ctDNA
#cfDNA
2
21
51
0
11
45
Thanks
@ASCOPost
for highlighting our
@IASLC
statement paper on
#liquidbiopsy
. A great team work!
@drgandara
@UmbertoMalapel1
@giorgioscaglio3
@HwakeleeMD
@CharuAggarwalMD
@barlesi
@LeciaSequist
@danieltanmd
@lmsholl
@AbboshChris
@CharlesSwanton
@TonyMok9
@BenjaminBesseMD
& more
@ASCOPost
on our Consensus Statement from
@IASLC
congrats and thxs
@ChristianRolfo
@drgandara
for organizing and inviting us to join!
0
8
22
1
13
45
Happy to contribute with our paper about Liquid Biopsy with
@KatherineScilla
to the Heather Wakelee
@HwakeleeMD
section in
@SpringerNature
@isliquidbiopsy
@IASLC
#lcsm
@UMGCCC
@UMmedschool
@umsystem
3
15
46
Biomarker in Liquid Biopsy 🫁 Cancer Appears More AccuratePredicting IO Response Than Tumor Biopsy
@ddemiguelperez
@ogarrieta
@rrcolen
@drmuratak
@ANaingMD
@OncoAlert
@IsevOrg
@sitcancer
1
16
46
Our paper is published “Hypersensitivity Reactions to Selpercatinib Treatment With or Without prior IO in NSCLC” Libretto-001
@CarolineMccoach
@alexdrilon
@ViolaWZhu
@BenjaminBesseMD
@danieltanmd
@RetRenegades
@RETpositive
@IASLC
@JTOonline
@OncoAlert
1
17
46
This is a paradigm change: showing for first time something we hypnotize “Platelets educate CTCs” by transferring lipids, proteins and RNA through different mechanisms. Thanks
@MJOSESERRANO19
for lead this multidisciplinary effort in
#liquidbiopsy
@isliquidbiopsy
@MSHSThoracicOnc
New from
@ChristianRolfo
,
@MJOSESERRANO19
, and colleagues: Exchange of cellular components between platelets and tumor cells: impact on tumor
cells behavior
@IcahnMountSinai
0
9
18
0
17
44
Time to support great colleagues for
@ASCO
elections
@DrChoueiri
@JhanelleGray
@CharuAggarwalMD
@DrSGraff
@clarissamathias
Congrats for the nominations!
Vote 🗳️!
Voting for the ASCO Election is now open. All eligible members are encouraged to cast their ballots.
🗳️ Vote now:
0
30
46
0
13
46
Congrats to all the
@ialsc
Academy participants! Great presentations!
@mangliorizzo
@ccg_galvez
@mihaela_aldea
@KLeventakos
@COlazagasti
@josephcmurray
@HaradaGuilherme
#WCLC22
1
9
45